Eledon Pharmaceuticals Inc. (NASDAQ: ELDN) Stock Information | RedChip

Eledon Pharmaceuticals Inc. (NASDAQ: ELDN)


$4.2900
+0.1000 ( +2.88% ) 218.0K

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for patients living with ALS. The company's compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.

Market Data


Open


$4.2900

Previous close


$4.1900

Volume


218.0K

Market cap


$248.52M

Day range


$3.9500 - $4.2950

52 week range


$1.5199 - $5.5400

SEC Filings


Form Type Description Pages Date
10-k/a Quarterly Reports 13 Apr 26, 2024
10-k Annual reports 81 Mar 28, 2024
8-k 8K-related 13 Mar 28, 2024

Latest News